Narcotic Drugs & Psychotropic Substances NDPS
Guiding you through life’s most sensitive legal challenges with compassion and expertise.
1. Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985
Overview
Enacted by the Indian Parliament to regulate and prohibit the production, sale, possession, and consumption of narcotic drugs and psychotropic substances.
Permits use of such substances strictly for medicinal or scientific purposes.
Aims to consolidate drug-related laws and establish stringent control mechanisms.
Key Provisions & Features
Prohibits:
Cultivation of specified plants.
Production, manufacture, possession, sale, purchase, transport, storage, and consumption of narcotic and psychotropic substances.
Graded Punishments Based on Quantity:
Small quantity: Imprisonment up to 1 year and/or fine up to ₹10,000.
Intermediate quantity: Imprisonment up to 10 years and fine up to ₹1 lakh.
Commercial quantity: Imprisonment from 10 to 20 years and fine between ₹1 lakh and ₹2 lakh (with scope for higher fines).
Establishment of the Narcotics Control Bureau (NCB) in 1986 for coordinated enforcement.
Provision for forfeiture of property acquired through illicit drug trafficking.
Alignment with international drug control conventions.
Immunity granted to drug addicts who voluntarily seek de-addiction treatment.
Significant Amendments
1988: Introduced stricter provisions to strengthen enforcement.
2001: Rationalized sentencing structures and provided support mechanisms for drug addicts.
2014: Relaxed regulations concerning essential narcotic drugs for medical use; removed mandatory death penalty for certain repeat offenses.
2021: Addressed and corrected a legislative drafting error.
Criticisms & Concerns
Lack of differentiation in punishment for various drug types, potentially incentivizing trade in more harmful substances.
Penalization of personal drug consumption, viewed by many as a public health issue rather than purely a criminal offense.
The Way Forward
Represents India’s ongoing effort to balance punitive measures with rehabilitative approaches.
Continued debates and periodic amendments indicate evolving perspectives on national and global drug policy frameworks.